Jay Bradner joins Amgen to lead R&D as David Reese moves to new chief technology officer rolenews2023-12-14T15:43:34+00:00December 14th, 2023|Endpoints News|
Grocery delivery giant Instacart is betting that food as medicine programs will help grow its businessnews2023-12-14T14:17:24+00:00December 14th, 2023|Endpoints News|
Former execs from Pfizer obesity drug program have started a new biotech with $52M from VC fund ATPnews2023-12-14T12:30:29+00:00December 14th, 2023|Endpoints News|
Updated: Metabolic drug developer HighTide Therapeutics eyes $36M raise with HK IPOnews2023-12-14T12:29:43+00:00December 14th, 2023|Endpoints News|
Headed to San Francisco? Here’s how you can customize your experience at #JPM24 with Endpoints Newsnews2023-12-14T12:22:31+00:00December 14th, 2023|Endpoints News|
Pathos AI makes successful takeover bid for Rain Oncologynews2023-12-14T12:08:15+00:00December 14th, 2023|Endpoints News|
White House keeps focus on lowering drug prices, turns Regeneron’s contract language into new standardnews2023-12-14T12:04:07+00:00December 14th, 2023|Endpoints News|
FDA puts three CARsgen CAR-T therapies on clinical hold, including Moderna-partnered programnews2023-12-14T11:53:59+00:00December 14th, 2023|Endpoints News|
Moderna, Merck unveil three-year mid-stage data for vaccine-Keytruda combo in melanoma, with PhIII underwaynews2023-12-14T11:48:28+00:00December 14th, 2023|Endpoints News|
Encellin raises about $10M for type 1 diabetes cell replacement therapynews2023-12-13T13:00:29+00:00December 13th, 2023|Endpoints News|
